Evaluation effect of human chorionic gonadotropin on pregnancy outcome in infertile patients

Not Applicable

• Conditions: Condition 1: IVF. Condition 2: ICSI. Condition 3: Infertility.; In vitro fertilization Admission for harvesting or implantation of ova; Artificial insemination; Complications of attempted introduction of embryo in embryo transfe

• Registration Number: IRCT2017041733486N1
• Lead Sponsor: Vice Chancellor Of Research,Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 300

Inclusion Criteria

Exclusion criteria:patients with a history of utrine surgery such as myomectmy;Patients with a history of recurrent miscarriage;Patients with known hydrosalpinx;Patients with endometriosis and endometroma;Patients with history of RIF(>3);Patients >40 years ;All patients under age 40 years who refer to Omid fertility centre and shariati hospital who suffered from infertility.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Embryo implantation. Timepoint: 4 weeks after transfer. Method of measurement: Sonography.;Chemical pregnancy. Timepoint: 2 weeks after transfer. Method of measurement: pregnancy test(BHCG test).;Clinical pregnancy. Timepoint: 4-5 weeks after emberyo transfer. Method of measurement: observation of fetal heart activity by transvaginal ultrasonography.

Secondary Outcome Measures

Name	Time	Method
Abortion. Timepoint: 2-4 weeks after transfer. Method of measurement: By sonography,clincal finding, pregnancy test.;Ectopic pregnancy. Timepoint: 4weeks after transfer. Method of measurement: by sonography ,pregnancy test.